Yara L Verschoor

6PUBLICATIONS
21CO-AUTHORS
Molecular targetsArt historyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 20, 2025
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.

Pedro B Tan, Yara L Verschoor, José G van den Berg

|Jul 30, 2025
Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence.

Alexander O Pasternak, Pien M van Paassen, Yara L Verschoor

|Sep 15, 2024
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

Peter G M de Gooyer, Yara L Verschoor, Lauren D W van den Dungen

|Jun 05, 2024
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.

Myriam Chalabi, Yara L Verschoor, Pedro Batista Tan

|Jan 08, 2024
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.

Yara L Verschoor, Joris van de Haar, José G van den Berg

Pageof 1